Literature DB >> 18050042

First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity.

H L Müller1, U Gebhardt, V Wessel, S Schröder, R Kolb, N Sörensen, J Maroske, E Hanisch.   

Abstract

Craniopharyngiomas are embryogenic malformations which lead to eating disorders and morbid obesity due to hypothalamic involvement in about 50% of all patients with pediatric craniopharyngioma. The experience with laparoscopic adjustable gastric banding (LAGB) in obese craniopharyngioma patients is limited. We are reporting on four patients with childhood craniopharyngioma diagnosed at age 2, 11, 12, and 21 years. BMI-SDS at diagnosis was +0.9, +4.5, +4.7 and -0.1 SD. During follow-up, all patients developed morbid obesity (BMI-SDS: +13.9, +10.3, +11.4, +7.3) so that 11, 6, 9 and 3 years after diagnosis LAGB were performed. After a follow-up of 4.5, 1.5, 3.0 and 2.5 years BMI decreased or stabilized continuously in all patients (BMI-SDS at latest visit: +9.9, +9.7, +9.5, +5.9 SD). The eating behavior changed in all patients profoundly. The addiction to food and especially sweets significantly improved based on self-assessment. In two patients a dislocation of the LAGB occurred and resulted in weight gain. We conclude that LAGB could be effective in weight reduction of obese craniopharyngioma patients with hypothalamic syndrome. Close follow-up is necessary in order to analyze long-term effects and complications of LAGB in patients with childhood craniopharyngioma and morbid obesity.

Entities:  

Mesh:

Year:  2007        PMID: 18050042     DOI: 10.1055/s-2007-985848

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  15 in total

1.  Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery.

Authors:  Gabrielle Page-Wilson; Sharon L Wardlaw; Alexander G Khandji; Judith Korner
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 2.  Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2010-09-28       Impact factor: 43.330

Review 3.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

4.  Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery.

Authors:  Taninee Sahakitrungruang; Tippayakarn Klomchan; Vichit Supornsilchai; Suttipong Wacharasindhu
Journal:  Eur J Pediatr       Date:  2010-11-25       Impact factor: 3.183

Review 5.  Childhood craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

6.  Practical approach to childhood craniopharyngioma: a role of an endocrinologist and a general paediatrician.

Authors:  Maria A Kalina; Eliza Skala-Zamorowska; Barbara Kalina-Faska; Ewa Malecka-Tendera; Marek Mandera
Journal:  Childs Nerv Syst       Date:  2009-06-17       Impact factor: 1.475

7.  Duodenal-jejunal bypass restores insulin action and βeta-cell function in hypothalamic-obese rats.

Authors:  Maria Lúcia Bonfleur; Rosane Aparecida Ribeiro; Audrei Pavanello; Raul Soster; Camila Lubaczeuski; Allan Cezar Faria Araujo; Antonio Carlos Boschero; Sandra Lucinei Balbo
Journal:  Obes Surg       Date:  2015-04       Impact factor: 4.129

Review 8.  Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans.

Authors:  Michelle Lee; Judith Korner
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

9.  Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits.

Authors:  Christian L Roth
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-14       Impact factor: 5.555

10.  Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience.

Authors:  Michal Cohen; Sharon Guger; Jill Hamilton
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.